LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Clinical trials for LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial aims to stop lung Cancer's return with powerful drug combo
Disease control Recruiting nowThis study is for people who have had surgery to remove stage II or III non-small cell lung cancer. It tests whether adding a drug called pembrolizumab (an immunotherapy) to standard chemotherapy after surgery is better at keeping the cancer from coming back. Researchers want to …
Matched conditions: LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 02:06 UTC
-
New drug aims to boost cancer treatment effectiveness
Disease control Recruiting nowThis study is testing whether adding an experimental drug called TRC102 to standard treatment helps people with stage III non-squamous non-small cell lung cancer live longer without their cancer getting worse. About 42 participants will receive either the standard treatment (chem…
Matched conditions: LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC